| |
| | United States Patent Application: 0020032171 (Site not responding. Last check: 2007-10-14) |
 | | The pharmaceutical composition of claim 52, wherein the ester is selected from the group consisting of ethyl propionate, tributylcitrate, acetyl triethylcitrate, acetyl tributyl citrate, triethylcitrate, ethyl oleate, ethyl caprylate, ethyl butyrate, triacetin, propylene glycol monoacetate, propylene glycol diacetate,.epsilon.-caprolactone and isomers thereof,.delta.-valerolactone and isomers thereof,.beta.-butyrolactone and isomers thereof, and mixtures thereof. |
 | | The pharmaceutical composition of claim 51, wherein the solubilizer is selected from the group consisting of triacetin, triethylcitrate, ethyl oleate, ethyl caprylate, dimethylacetamide, N-methylpyrrolidone, N-hydroxyethylpyrrolidone, polyvinylpyrrolidone, hydroxypropyl methylcellulose, hydroxypropyl cyclodextrins, ethanol, polyethylene glycol 200-600, glycofurol, transcutol, propylene glycol, dimethyl isosorbide and mixtures thereof. |
 | | The pharmaceutical composition of claim 132, wherein the ester is selected from the group consisting of ethyl propionate, tributylcitrate, acetyl triethylcitrate, acetyl tributyl citrate, triethylcitrate, ethyl oleate, ethyl caprylate, ethyl butyrate, triacetin, propylene glycol monoacetate, propylene glycol diacetate,.epsilon.-caprolactone and isomers thereof,.delta.-valerolactone and isomers thereof,.beta.-butyrolactone and isomers thereof, and mixtures thereof. |
| appft1.uspto.gov /netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=/netahtml/PTO/search-adv.html&r=1&f=G&l=50&d=PG01&p=1&S1=20020032171&OS=20020032171&RS=20020032171 (10146 words) |
|